603 related articles for article (PubMed ID: 19682670)
1. Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism.
Stein PD; Hull RD; Matta F; Yaekoub AY; Liang J
Am J Med; 2009 Oct; 122(10):919-30. PubMed ID: 19682670
[TBL] [Abstract][Full Text] [Related]
2. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
4. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007.
Raffini L; Huang YS; Witmer C; Feudtner C
Pediatrics; 2009 Oct; 124(4):1001-8. PubMed ID: 19736261
[TBL] [Abstract][Full Text] [Related]
5. Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxis.
Wang TY; Honeycutt EF; Tapson VF; Moll S; Granger CB; Ohman EM
Am J Med; 2012 Dec; 125(12):1214-21. PubMed ID: 22939359
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin.
Pohl C; Kredteck A; Bastians B; Hanfland P; Klockgether T; Harbrecht U
Neurology; 2005 Apr; 64(7):1285-7. PubMed ID: 15824368
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
[TBL] [Abstract][Full Text] [Related]
8. Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.
Amin AN; Lin J; Lenhart G; Schulman KL
Thromb Haemost; 2009 Aug; 102(2):321-6. PubMed ID: 19652883
[TBL] [Abstract][Full Text] [Related]
9. Prevention of venous thromboembolism in hospitalized medical patients.
Lenchus JD; Jaffer AK
Mt Sinai J Med; 2008 Oct; 75(5):449-53. PubMed ID: 18828167
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes.
Baroletti S; Piovella C; Fanikos J; Labreche M; Lin J; Goldhaber SZ
Thromb Haemost; 2008 Dec; 100(6):1130-5. PubMed ID: 19132240
[TBL] [Abstract][Full Text] [Related]
11. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.
Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM
J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparin in pediatric patients.
Sutor AH; Chan AK; Massicotte P
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():31-9. PubMed ID: 15085464
[TBL] [Abstract][Full Text] [Related]
13. Adherence to pharmacological thromboprophylaxis orders in hospitalized patients.
Fanikos J; Stevens LA; Labreche M; Piazza G; Catapane E; Novack L; Goldhaber SZ
Am J Med; 2010 Jun; 123(6):536-41. PubMed ID: 20569760
[TBL] [Abstract][Full Text] [Related]
14. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
15. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.
ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW
Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229
[TBL] [Abstract][Full Text] [Related]
16. Heparin-induced thrombocytopenia in surgical patients.
Battistelli S; Genovese A; Gori T
Am J Surg; 2010 Jan; 199(1):43-51. PubMed ID: 20103065
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials.
Wein L; Wein S; Haas SJ; Shaw J; Krum H
Arch Intern Med; 2007 Jul; 167(14):1476-86. PubMed ID: 17646601
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J
Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498
[TBL] [Abstract][Full Text] [Related]
20. Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital.
Ban-Hoefen M; Francis C
Thromb Res; 2009 Jun; 124(2):189-92. PubMed ID: 19195684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
